Data supportive of CX-801’s mechanism of action and the ongoing Phase 1 combination study with KEYTRUDA® (pembrolizumab) - SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CytomX ...
Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Good afternoon, everyone. Thank you for standing by. Welcome to ...
The first patient has been dosed in a first-in-human phase 1 trial evaluating DS3610 in patients with advanced, metastatic or ...
The research conducted by Professor Zou Zui and his team focuses on the immunoregulatory mechanisms in sepsis. As a ...
Daiichi Sankyo’s DS3610 enters clinical development in patients with advanced solid tumours: Tokyo Wednesday, November 12, 2025, 11:00 Hrs [IST] Daiichi Sankyo, an innovative gl ...
Claseprubart achieved statistically significant and clinically meaningful improvements in Myasthenia Gravis Activities of Daily Living (MG-ADL), ...
Verywell Health on MSN
5 Supplements to Take With Magnesium to Boost Its Benefits
Magnesium is essential for several bodily processes, including energy production, muscle and nerve health, and blood pressure regulation. Pairing it with certain supplements can help enhance its ...
BackgroundSepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and multi-organ dysfunction. It ...
Researchers uncover that ALV-J boosts miR-155 to suppress TRAF3 and STAT1, weakening immune responses and promoting viral replication in poultry.
Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 is the first highly potent and selective Kv1.3 blocker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback